Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Janney Montgomery Scott Upgrades EPR Props to Buy

Janney Montgomery Scott Upgrades EPR Props to Buy

Janney Montgomery Scott analyst Robert Stevenson upgrades EPR Props (NYSE:EPR) from Neutral to Buy.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Janney Montgomery Scott analyst Robert Stevenson upgrades EPR Props (NYSE:EPR) from Neutral to Buy.

Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $33

By Benzinga Newsdesk

December 13, 10:34 AM

Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $36 to $33.

TDOC

Vertex Pharmaceuticals’ Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients

By Vandana Singh

February 6, 10:57 AM

Vertex Pharmaceuticals' vanza triple program for cystic fibrosis, with superior results in lung function, sweat chloride reduction, and safety.

VRTX

Constellation Brands Q4 Highlights: 5% Sales Decline, Bottomline Beat, Dividend Hike & More

By Shivani Kumaresan

April 6, 9:41 AM

Constellation Brands, Inc. (NYSE:STZ) reported a fourth-quarter FY23 sales decline of 5% year-on-year to $1.997 billion, missing the consensus of $2.02…

STZ

Fiserv FY23 EPS Putlook $7.25 – $7.40 Vs. $7.28 Estimate

By Benzinga Newsdesk

February 7, 8:09 AM

Outlook for 2023 Fiserv expects organic revenue growth of 7% to 9% and adjusted earnings per share of $7.25 to $7.40, representing growth of 12% to 14%, for 2023. "Heading into an uncertain 2023, we remain

FISV

Janney Montgomery Scott Upgrades EPR Props to Buy

Related Posts

Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $33

Vertex Pharmaceuticals’ Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients

Constellation Brands Q4 Highlights: 5% Sales Decline, Bottomline Beat, Dividend Hike & More

Fiserv FY23 EPS Putlook $7.25 – $7.40 Vs. $7.28 Estimate